Jake Becraft is the CEO/Co-Founder at Strand Therapeutics, the leading next-generation mRNA therapeutics company. During his PhD at MIT, he led the development of the world’s first programmable platform for mRNA therapeutics. This technology enabled the delivery of therapies to areas of the body currently unreachable by traditional mRNA technologies and promises to revolutionize how medicines are designed for oncology, cell therapy, gene editing, and beyond. Beyond running Strand, Jake also serves as a Science and Technology advisor to legislators in DC and the Massachusetts State House. He is a Board Director for MassBio and the Biotechnology Innovation Organization (BIO).